Advanced yolk sac tumor, neoadjuvant chemotherapy, primary surgery, cytoreduction, survival
Epithelioid trophoblastic tumor, Prognostic model, Clinicopathological characteristics, Progression-free survival
Toripalimab, PD-1 inhibitor, cervical cancer, combination therapy, bevacizumab, chemotherapy